End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,959 KRW | -11.56% | -2.05% | +7.76% |
04-05 | Enzychem Lifesciences Corporation announces an Equity Buyback for KRW 10,000 million worth of its shares. | CI |
04-05 | Enzychem Lifesciences Corporation authorizes a Buyback Plan. | CI |
Business Summary
Number of employees: 113
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Bio - Maintenance
53.8
%
| - | - | 40,927 | 53.8 % | - |
Drug Substance Other Product
45.0
%
| 25,630 | 96.2 % | 34,181 | 45.0 % | +33.36% |
Health Functional Food Product
1.2
%
| 1,007 | 3.8 % | 931 | 1.2 % | -7.58% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
93.3
%
| 23,868 | 89.6 % | 70,907 | 93.3 % | +197.08% |
Overseas
6.7
%
| 2,770 | 10.4 % | 5,132 | 6.7 % | +85.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 16-10-20 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 15-05-31 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 11-03-31 |
Hwang-Bae Kang
AUD | Comptroller/Controller/Auditor | 58 | 15-03-29 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gi-Young Sohn
CEO | Chief Executive Officer | 62 | 12-05-31 |
Hye-Kyung Kim
BRD | Director/Board Member | 66 | 12-06-30 |
Jae-Yong Lee
BRD | Director/Board Member | 62 | 11-03-31 |
Myung-Hwan Kim
BRD | Director/Board Member | 67 | 15-05-31 |
Do-Hyeon Jo
COO | Chief Operating Officer | 49 | 16-10-20 |
Chang-Ki Hong
BRD | Director/Board Member | 87 | 19-03-25 |
Hye-Young Oh
BRD | Director/Board Member | 68 | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 85,065,562 | 74,031,725 ( 87.03 %) | 0 | 87.03 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+7.76% | 138M | |
+30.38% | 695B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 330B | |
+3.73% | 283B | |
+16.70% | 239B | |
+8.78% | 204B | |
-7.93% | 198B | |
+7.68% | 168B |
- Stock Market
- Equities
- A183490 Stock
- Company Enzychem Lifesciences Corporation